The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
I aim to use high-quality laboratory science, clinical and social research, and strong public health principles, to address the major health problems of the Asia-Pacific region and improve health through translatable outcomes
I am a structural biologist investigating the structure and function of malaria surface proteins as vaccine candidates, regulators of cytokine signalling and pharmacologically active toxins.
Combating The Global Medical Challenge Caused By Gram-negative 'superbugs': From Redeveloping The Polymyxins To Discovering Novel Antibiotics
Funder
National Health and Medical Research Council
Funding Amount
$375,012.00
Summary
Bacterial �superbugs� are becoming a major global medical challenge. Polymyxins are the last-line antibiotics against Gram-negative �superbugs� but with little pharmacological information available. I am an antimicrobial pharmacologist specialised in re-developing polymyxins, and discovering novel antibiotics against these very troublesome bacteria. My research targets the _Bad Bugs, No Drugs� disaster highlighted by the Infectious Diseases Society of America and the World Health Organization.
I am a virologist and my overall research activity is to understand the basic biology of the human immunodeficiency virus (HIV) life-cycle including the role of interactions between viral proteins, and viral proteins and host cell factors in HIV replicati
I am a cancer molecular and cell biologist determining the mechanisms of anticancer drug action and resistance in both childhood and adult malignancies. My research involves the development and investigation of both in vivo and in vitro models of resistan
I am a cancer cell biologist investigating molecular mechanisms of leukaemia cell resistance to chemotherapeutic drugs, and novel strategies for the management of high risk or relapsed disease. For these purposes I have developed orthotopic xenograft mode